PanCAN’s Precision Promise Adaptive Clinical Trial Platform Locations

PanCAN’s Precision Promise Clinical Trial Consortium sites were selected through a competitive, peer-review process and include premier cancer treatment institutions across the country.

Cedars-Sinai Medical Center (Los Angeles, CA)
Principal investigator: Andrew Hendifar, MD

Dana-Farber/Harvard Cancer Center (Boston, MA)
Principal investigator: Brian Wolpin, MD, MPH

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance/University of Washington (Seattle, WA)
Principal investigator: Andrew Coveler, MD

Johns Hopkins Medicine (Baltimore, MD)
Principal Investigator: Daniel Laheru, MD

Memorial Sloan Kettering Cancer Center (New York City, NY)
Principal investigator: Eileen O’Reilly, MD

Moores Cancer Center at UC San Diego Health (San Diego, CA)
Principal investigator: Aaron Miller, MD

Perelman School of Medicine University of Pennsylvania (Philadelphia, PA)
Principal investigator: Gregory Beatty, MD, PhD

Perlmutter Cancer Center/NYU Langone Health (New York City, NY)
Principal investigator: Diane Simeone, MD

The University of Chicago (Chicago, IL)
Principal investigator: Hedy Kindler, MD

The University of Texas MD Anderson Cancer Center (Houston, TX)
Principal Investigator: Shubham Pant, MD

UC San Francisco Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)
Principal investigator: Andrew Ko, MD

University of Florida Health – Cancer Center (Gainesville, FL)
Principal investigator: Thomas George, MD, FACP

Virginia Mason Medical Center (Seattle, WA)
Principal investigator: Vincent Picozzi, MD

Washington University School of Medicine (St. Louis, MO)
Principal investigator: Kian-Huat Lim, MD, PhD

Weill Cornell Medicine (New York City, NY)
Principal investigator: Manuel Hidalgo, MD, PhD

PRECISION PROMISE^SM is a service mark of Pancreatic Cancer Action Network, Inc.